MyAverix Finance
AU · Healthcare
Mesoblast Ltd (MSB)
Biotechnology
Mesoblast Ltd (MSB) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MSB
Mesoblast Ltd (MSB) — FAQ
What is MSB's P/E ratio?
The price-to-earnings (P/E) ratio for Mesoblast Ltd (MSB) is 18.00 (data as of 2026-03-22).
Does Mesoblast Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Mesoblast Ltd (MSB). Check the MyAverix Finance app for the latest dividend data.
What sector is Mesoblast Ltd in?
Mesoblast Ltd (MSB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MSB listed on?
MSB is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.